Search results
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
From quarterly updates to key announcements, here you can access GSK investor-related information.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
5 days ago · GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian...
Per-Share Earnings, Actuals and Estimates. View the latest GSK PLC (GSK) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Jul 3, 2024 · GSK has reached a licensing agreement with mRNA vaccine developer CureVac worth up to €1.4bn to develop its vaccines for flu, Covid-19 and avian flu. The UK drugmaker has an existing ...
Jul 3, 2024 · GSK Plc agreed to pay as much as €1.4 billion ($1.5 billion) for the full rights to mRNA flu and Covid-19 shots it was developing with CureVac NV as the German biotech refocuses on cancer vaccines.
